| Name | Title | Contact Details |
|---|
AllStripes is a healthcare technology company dedicated to unlocking new treatments for people with rare diseases. AllStripes has developed a technology platform that generates regulatory-ready evidence to accelerate rare disease research and drug development, as well as a patient application that empowers patients and families to securely participate in treatment research online and benefit from their own medical data. AllStripes was founded by CEO Nancy Yu and technology developer Onno Faber, following his diagnosis and journey with the rare disease neurofibromatosis type 2. The company is backed by Lux Capital, JAZZ Venture Partners, Spark Capital, Medidata Solutions, McKesson Ventures, Maveron, and a number of angel investors.
We are harnessing the power of the immune system to target some of the most challenging solid tumor malignancies.
Eidos Therapeutics, a subsidiary of BridgeBio Pharma, is developing AG10 as a targeted therapeutic for transthyretin amyloidosis.
CorneaGen is a mission-driven company committed to transforming how corneal surgeons treat and care for the cornea.
Odyssey Research Services is a Bismarck, ND-based company in the Healthcare, Pharmaceuticals, & Biotech sector.